癌痛治疗不足的现状与原因
Status and Relevant Causes of Cancer Pain Undertreatment
查看参考文献27篇
文摘
|
本文旨在以综述的方式对于癌痛治疗不足的现状、原因以及应对措施进行汇总,进而为改善临床癌痛治疗提供参考。对于癌痛治疗以及治疗不足的现状进行了汇总和总结,对于癌痛治疗不足的原因和应对措施进行了归纳和分析。今后癌痛治疗的规范化、癌痛的正确评估以及加强癌痛治疗的宣教仍然是癌痛治疗研究的重点方向。 |
其他语种文摘
|
To review the current situations, causes and solutions of cancer pain undertreatment, which could provide some reference for future study and clinical therapy. The current conditions of cancer pain therapy and inadequate pain control in patients with cancer are collected and summarized. The factors and causes for inadequate cancer pain control are concluded and analyzed. Proper and normalized pain treatment and management, correct pain assessment and documentation and extensive education of cancer pain control in patients and doctors will be the key direction in future study. |
来源
|
肿瘤防治研究
,2014,41(4):421-424 【扩展库】
|
关键词
|
癌痛
;
癌痛治疗
;
阿片类镇痛药
;
镇痛不足
|
地址
|
北京协和医学院中国医学科学院肿瘤医院麻醉科, 北京, 100021
|
语种
|
中文 |
文献类型
|
综述型 |
ISSN
|
1000-8578 |
学科
|
肿瘤学 |
文献收藏号
|
CSCD:5128349
|
参考文献 共
27
共2页
|
1.
Shaheen P E. Errors in opioid prescribing: a prospective survey in cancer pain.
J Pain Symptom Manage,2010,39(4):702-711
|
CSCD被引
7
次
|
|
|
|
2.
Body J J. Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer.
Pain,2004,111(3):306-312
|
CSCD被引
4
次
|
|
|
|
3.
Apolone G. Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group.
Br J Cancer,2009,100(10):1566-1574
|
CSCD被引
3
次
|
|
|
|
4.
Ripamonti C. Strategies for the treatment of cancer pain in the new millennium.
Drugs,2001,61(7):955-977
|
CSCD被引
5
次
|
|
|
|
5.
Anton A. Pain in clinical oncology: patient satisfaction with management of cancer pain.
Eur J Pain,2012,16(3):381-389
|
CSCD被引
2
次
|
|
|
|
6.
Deandrea S. Prevalence of undertreatment in cancer pain. A review of published literature.
Ann Oncol,2008,19(12):1985-1991
|
CSCD被引
15
次
|
|
|
|
7.
王雅杰. 癌痛治疗需转变观念.
药学服务研究,2009,9(2):81-83
|
CSCD被引
3
次
|
|
|
|
8.
Stephenson N. Racial and ethnic disparities in cancer pain management.
J Natl Black Nurses Assoc,2009,20(1):11-18
|
CSCD被引
1
次
|
|
|
|
9.
Beck S L. An ethnographic study of factors influencing cancer pain management in South Africa.
Cancer Nurs,2000,23(2):91-99
|
CSCD被引
1
次
|
|
|
|
10.
Mercadante S. World Health Organization guidelines for cancer pain: a reappraisal.
Ann Oncol,2005,16(Suppl 4):iv132-iv135
|
CSCD被引
5
次
|
|
|
|
11.
Caraceni A. Cancer pain assessment in clinical trials. A review of the literature (1999-2002).
J Pain Symptom Manage,2005,29(5):507-519
|
CSCD被引
2
次
|
|
|
|
12.
Starck P L. Identifying and addressing medical errors in pain mismanagement.
Jt Comm J Qual Improv,2001,27(4):191-199
|
CSCD被引
2
次
|
|
|
|
13.
郑莹. 上海市医生对癌症疼痛治疗认识的调查.
中国肿瘤,2001,10(7):393-395
|
CSCD被引
8
次
|
|
|
|
14.
Nunes B C. Morphine as the fi rst drug for the treatment of cancer pain.
J Palliat Med,2012,15(9):963-964
|
CSCD被引
3
次
|
|
|
|
15.
罗帼英. 癌痛病人缺乏规范止痛治疗状况的调查研究.
护理研究,2011,25(3):204-205
|
CSCD被引
1
次
|
|
|
|
16.
McNicol E. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review.
J Pain,2003,4(5):231-256
|
CSCD被引
8
次
|
|
|
|
17.
Kim H S. Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors.
Support Care Cancer,2013,21(6):1751-1759
|
CSCD被引
3
次
|
|
|
|
18.
Kircher S. Understanding and treating opioid addiction in a patient with cancer pain.
J Pain,2011,12(10):1025-1031
|
CSCD被引
1
次
|
|
|
|
19.
Katz N P. Volume of prescription opioids used nonmedically in the United States.
J Pain Palliat Care Pharmacother,2010,24(2):141-144
|
CSCD被引
1
次
|
|
|
|
20.
Gourlay D L. Pain and addiction: managing risk through comprehensive care.
J Addict Dis,2008,27(3):23-30
|
CSCD被引
1
次
|
|
|
|
|